deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02125357

Sequencing Abiraterone and Enzalutamide in mCRPC

A Randomized Phase II Study of Sequencing Abiraterone Acetate and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Sponsor: British Columbia Cancer Agency

Conditions Metastatic Castration-Resistant Prostate Cancer
Interventions Abiraterone acetate Enzalutamide
Updated 11 times since 2017 Last updated: Aug 6, 2020 Started: Sep 30, 2014 Primary completion: Feb 4, 2020 Completion: Feb 4, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Metastatic Castration-Resistant Prostate Cancer, this trial is completed. The trial is conducted by British Columbia Cancer Agency and has accumulated 11 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshotActive Not Recruiting~Aug 2018 – ~Feb 2019 · 6 months · monthly snapshotActive Not Recruiting~Feb 2019 – ~Aug 2019 · 6 months · monthly snapshotActive Not Recruiting~Aug 2019 – ~Feb 2020 · 6 months · monthly snapshotActive Not Recruiting~Feb 2020 – ~Sep 2020 · 7 months · monthly snapshotActive Not Recruiting~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Sep 2020 — Jan 2021 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  5. Feb 2020 — Sep 2020 [monthly]

    Active Not Recruiting PHASE2

▶ Show 6 earlier versions

  1. Aug 2019 — Feb 2020 [monthly]

    Active Not Recruiting PHASE2

  2. Feb 2019 — Aug 2019 [monthly]

    Active Not Recruiting PHASE2

  3. Aug 2018 — Feb 2019 [monthly]

    Active Not Recruiting PHASE2

  4. Jun 2018 — Aug 2018 [monthly]

    Active Not Recruiting PHASE2

  5. Feb 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  6. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • British Columbia Cancer Agency
Data source: British Columbia Cancer Agency

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations